Susan Mason

4.4k total citations · 1 hit paper
33 papers, 2.1k citations indexed

About

Susan Mason is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Susan Mason has authored 33 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Cell Biology. Recurrent topics in Susan Mason's work include Cancer Cells and Metastasis (4 papers), CRISPR and Genetic Engineering (4 papers) and Immune Cell Function and Interaction (4 papers). Susan Mason is often cited by papers focused on Cancer Cells and Metastasis (4 papers), CRISPR and Genetic Engineering (4 papers) and Immune Cell Function and Interaction (4 papers). Susan Mason collaborates with scholars based in United Kingdom, Canada and United States. Susan Mason's co-authors include Karen Blyth, Karen H. Vousden, Oliver D.K. Maddocks, Eyal Gottlieb, Celia R. Berkers, Liang Zheng, Stephen W. G. Tait, Dimitris Athineos, Josephine Walton and Daniel J. Murphy and has published in prestigious journals such as Nature, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Susan Mason

32 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells

2012 745 citations Oliver D.K. Maddocks, Susan Mason et al. profile →

Peers

Susan Mason

ONCOL

IMMUN

Sandy Giuliano France

Jinyang Li United States

Go J. Yoshida Japan

Michel Nofal United States

Patrick A. Mayes United States

Simone Di Franco Italy

Brian F. Clem United States

Aya Kobayashi Japan

Nako Maishi Japan

Debangshu Samanta United States

Sandy Giuliano France

Susan Mason

1.4k ×1.0

554 ×0.8

656 ×1.0

ONCOL

335 ×0.9

IMMUN

280 ×1.4

Citations per year, relative to Susan Mason Susan Mason (= 1×) peers Sandy Giuliano

Countries citing papers authored by Susan Mason

Since Specialization

Citations

This map shows the geographic impact of Susan Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Mason more than expected).

Fields of papers citing papers by Susan Mason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Mason. The network helps show where Susan Mason may publish in the future.

Co-authorship network of co-authors of Susan Mason

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Mason. A scholar is included among the top collaborators of Susan Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Mason. Susan Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Santi, Alice, Emily Kay, Lisa J. Neilson, et al.. (2024). Cancer-associated fibroblasts produce matrix-bound vesicles that influence endothelial cell function. Science Signaling. 17(827). eade0580–eade0580. 14 indexed citations

Sandilands, Emma, Álvaro Román‐Fernández, Lynn McGarry, et al.. (2023). The small GTPase ARF3 controls invasion modality and metastasis by regulating N-cadherin levels. The Journal of Cell Biology. 222(4). 4 indexed citations

Sandilands, Emma, Álvaro Román‐Fernández, Susan Mason, et al.. (2021). An ARF GTPase module promoting invasion and metastasis through regulating phosphoinositide metabolism. Nature Communications. 12(1). 1623–1623. 10 indexed citations

Castino, Giovanni Francesco, Susan Mason, William Clark, et al.. (2021). MICAL1 regulates actin cytoskeleton organization, directional cell migration and the growth of human breast cancer cells as orthotopic xenograft tumours. Cancer Letters. 519. 226–236. 14 indexed citations

Campbell, Kirsteen J., Susan Mason, Catherine Cloix, et al.. (2021). Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic function. Cell Death and Differentiation. 28(9). 2589–2600. 31 indexed citations

Rooney, Nicholas, Susan Mason, Laura McDonald, et al.. (2020). RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome. Cancer Research. 80(11). 2325–2339. 29 indexed citations

Ran, Ran, Hannah Harrison, Wensheng Deng, et al.. (2020). A role for CBFβ in maintaining the metastatic phenotype of breast cancer cells. Oncogene. 39(12). 2624–2637. 11 indexed citations

Mével, Renaud, Susan Mason, Laura C.A. Galbraith, et al.. (2020). RUNX1 marks a luminal castration-resistant lineage established at the onset of prostate development. eLife. 9. 27 indexed citations

Neilson, Matthew, June Munro, Gabriela Kalna, et al.. (2019). Migration through physical constraints is enabled by MAPK-induced cell softening via actin cytoskeleton re-organization. Journal of Cell Science. 132(11). 36 indexed citations

10.

Campbell, Kirsteen J., Sandeep Dhayade, Nicola Ferrari, et al.. (2018). MCL-1 is a prognostic indicator and drug target in breast cancer. Cell Death and Disease. 9(2). 19–19. 144 indexed citations

11.

Walton, Josephine, Malcolm Farquharson, Susan Mason, et al.. (2017). CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity. PMC. 2 indexed citations

12.

Walton, Josephine, Julianna Blagih, Darren Ennis, et al.. (2016). CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma. Cancer Research. 76(20). 6118–6129. 150 indexed citations

13.

Ferrari, Nicola, Alessandra I. Riggio, Susan Mason, et al.. (2015). Runx2 contributes to the regenerative potential of the mammary epithelium. Scientific Reports. 5(1). 15658–15658. 28 indexed citations

14.

Ichim, Gabriel, Jonathan Lopez, Shafiq U. Ahmed, et al.. (2015). Limited Mitochondrial Permeabilization Causes DNA Damage and Genomic Instability in the Absence of Cell Death. Molecular Cell. 57(5). 860–872. 336 indexed citations

15.

Ferrari, Nicola, Zahra Mohammed, Colin Nixon, et al.. (2014). Expression of RUNX1 Correlates with Poor Patient Prognosis in Triple Negative Breast Cancer. PLoS ONE. 9(6). e100759–e100759. 70 indexed citations

16.

Hock, Andreas, Pearl Lee, Oliver D.K. Maddocks, et al.. (2013). iRFP is a sensitive marker for cell number and tumor growth in high-throughput systems. Cell Cycle. 13(2). 220–226. 33 indexed citations

17.

Ridgway, Rachel A., Bryan Serrels, Susan Mason, et al.. (2012). Focal adhesion kinase is required for β-catenin-induced mobilization of epidermal stem cells. Carcinogenesis. 33(12). 2369–2376. 26 indexed citations

18.

Li, Ang, Yafeng Ma, Meng Jin, et al.. (2012). Activated Mutant NRasQ61K Drives Aberrant Melanocyte Signaling, Survival, and Invasiveness via a Rac1-Dependent Mechanism. Journal of Investigative Dermatology. 132(11). 2610–2621. 47 indexed citations

19.

Serrels, Bryan, Alan Serrels, Susan Mason, et al.. (2008). A novel Src kinase inhibitor reduces tumour formation in a skin carcinogenesis model. Carcinogenesis. 30(2). 249–257. 28 indexed citations

20.

Mason, Susan, et al.. (2004). Cyclic Adenosine 5′-Monophosphate Response Element Binding Protein Plays a Central Role in Mediating Proliferation and Differentiation Downstream of the Pre-TCR Complex in Developing Thymocytes. The Journal of Immunology. 173(3). 1802–1810. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact